Related Experiment Videos
Pentacyclic triterpenoids from Aster ageratoides var. pilosus
Fu-Lin Yan1, Ai-Xia Wang, Zhong-Jian Jia
1College of Chemistry and Chemical Engineering, National Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou, PR China.
Die Pharmazie
|December 14, 2004
Summary
Researchers isolated two new pentacyclic triterpenoids from Aster ageratoides var. pilosus roots. Compound 2 showed promising anti-bacterial and anti-tumor activities, warranting further investigation.
Area of Science:
- Natural Product Chemistry
- Pharmacology
Background:
- Aster ageratoides var. pilosus is a plant species known for its potential medicinal properties.
- Triterpenoids are a class of naturally occurring compounds with diverse biological activities.
Purpose of the Study:
- To isolate and characterize new pentacyclic triterpenoids from Aster ageratoides var. pilosus.
- To evaluate the anti-bacterial and anti-tumor activities of isolated compounds.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation using spectroscopic methods, including IR, MS, 1H, 13C, and 2D NMR.
- In vitro testing of anti-bacterial and anti-tumor activities.
Main Results:
- Two novel pentacyclic triterpenoids (1 and 2) and two known compounds were isolated.
- The structures of the new compounds were fully determined through comprehensive spectroscopic analysis.
- Compound 2 demonstrated significant anti-bacterial and anti-tumor effects.
Conclusions:
- Aster ageratoides var. pilosus is a source of novel pentacyclic triterpenoids.
- Compound 2 exhibits potential as a therapeutic agent for bacterial infections and cancer.
- Further research is recommended to explore the pharmacological mechanisms of compound 2.